Skip to content

Novelion Therapeutics Inc.: filings

Every Novelion Therapeutics Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 32 filings, each linked to its SEC index.

Filing record ends 2019-05-07

The latest filing in this captured record is a 10-Q filed 2019-05-07. No later filing is in the SEC companyfacts record captured on 2026-09-22. Novelion Therapeutics Inc. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2019-05-07fiscal Q1 201946930000827809-19-000012
10-K2019-03-15fiscal FY 2018461090000827809-19-000005
10-Q2018-11-13fiscal Q3 2018411080000827809-18-000040
10-Q2018-08-07fiscal Q2 2018411040000827809-18-000032
10-Q2018-05-10fiscal Q1 201840820000827809-18-000016
10-K2018-03-16fiscal FY 2017461350000827809-18-000006
10-Q2017-11-09fiscal Q3 201738990000827809-17-000052
10-Q2017-08-08fiscal Q2 201737950000827809-17-000038
10-Q2017-05-09fiscal Q1 201737780000827809-17-000030
10-K2017-03-30fiscal FY 2016441140000827809-17-000012
10-Q2016-11-01fiscal Q3 201627900001193125-16-755505
10-Q2016-08-09fiscal Q2 201627880001193125-16-676820
10-Q2016-05-05fiscal Q1 201628600001193125-16-579808
10-K2016-02-25fiscal FY 201535930001193125-16-478534
10-Q2015-10-29fiscal Q3 201528910001193125-15-358162
10-Q2015-07-30fiscal Q2 201528900001193125-15-270476
10-Q2015-04-30fiscal Q1 201528590001193125-15-161037
10-K2015-02-26fiscal FY 201436950001193125-15-065836
10-Q2014-10-28fiscal Q3 201428930001193125-14-384635
10-Q2014-08-05fiscal Q2 201430900001193125-14-295994
10-Q2014-04-30fiscal Q1 201426530001193125-14-170937
10-K2014-02-28fiscal FY 201337970001193125-14-076512
10-Q2013-11-07fiscal Q3 201331970001193125-13-432329
10-Q2013-08-01fiscal Q2 2013331030001193125-13-314829
10-Q2013-05-02fiscal Q1 201333670001193125-13-196010
10-K2013-02-21fiscal FY 2012401050001193125-13-069517
10-Q2012-11-07fiscal Q3 2012361220001193125-12-457344
10-Q2012-08-02fiscal Q2 2012371220001193125-12-332233
10-Q2012-05-03fiscal Q1 201237780001193125-12-207941
10-K2012-02-23fiscal FY 2011381000001193125-12-075603
10-Q/A2011-11-03fiscal Q3 2011361220000950123-11-094929
10-Q2011-07-28fiscal Q2 2011371230000950123-11-069538

Inspect the source

Entity
Novelion Therapeutics Inc. / CIK 0000827809
Captured
SEC response SHA-256
ab848446492c17fa8d98779b2db5387bb57913edfc12694a1cd0e3f5ca9fc31d

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000827809.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))